(Q40693313)

22 September 2017

title

In vitro and in vivo treatment of colon cancer by VIP antagonists (English)

1 reference

22 September 2017

1 reference

Albert Levy

1

1 reference

22 September 2017

Rivka Gal

2

1 reference

22 September 2017

Ruth Granoth

3

1 reference

22 September 2017

Zeev Dreznik

4

1 reference

22 September 2017

Mati Fridkin

5

1 reference

22 September 2017

Illana Gozes

6

1 reference

22 September 2017

publication date

1 November 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

109

1 reference

22 September 2017

issue

1-3

1 reference

22 September 2017

page(s)

127-133

1 reference

Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Ontogeny of vasoactive intestinal peptide in the human fetal digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

A VIP hybrid antagonist: from developmental neurobiology to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Inhibition of human neuroblastoma growth by a specific VIP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Rat aortic smooth-muscle cell proliferation is bidirectionally regulated in a cell cycle-dependent manner via PACAP/VIP type 2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Fiber-derived butyrate and the prevention of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Preclinical and clinical strategies for development of telomerase and telomere inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

(Stearyl, Norleucine17)VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

VIP-derived sequences modified by N-terminal stearyl moiety induce cell death: the human keratinocyte as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

PACAP hybrid: a new PACAP receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

Multiple actions of a hybrid PACAP antagonist: neuronal cell killing and inhibition of sperm motility

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900195-7

7 January 2021

10.1016/S0167-0115(02)00195-7

Identifiers

DOI

1 reference

22 September 2017

1 reference